Search Results for " Alvespimycin "
Alvespimycin Related Products
Alvespimycin is a compound derived from geldanamycin and acts as an inhibitor of heat shock protein (HSP) 90. It has been investigated in clinical trials for its potential to treat solid tumors in various types of cancer as an antitumor agent. Compared to the first HSP90 inhibitor, tanespimycin, alvespimycin offers several beneficial pharmacological properties, including lower metabolic risk, reduced plasma protein binding, improved water solubility, enhanced oral bioavailability, decreased liver toxicity, and more effective antitumor activity.
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Alvespimycin, pharmacopeial and non-pharmacopeial Alvespimycin impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Alvespimycin impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.